Roche Group: Ledger

Stories naming Roche Group. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
Roche Group is not recorded as having acquired anything.

Name	Role	Sources
Dr Steve Burnell	Executive (former)	Business News Australia, Brandon Capital portfolio, Brandon BioCatalyst portfolio

2 deals

Billionaires Andrew and Nicola Forrest take aim at peanut allergy

Biotech Aravax has received a US$20 million Series B commitment from Brandon Capital and Tenmile to advance its peanut allergy therapy PVX108 into Phase 2 trials.

Brandon BioCatalyst portfolio 20 Dec 2022 Aravax Tenmile Carina Biotech Emyria Psylo Roche Group Rock Health Tattarang Brandon Capital Dr Andrew Forrest Dr Chris Smith Dr Dr Steve Burnell Nicola Forrest Dr Pascal Hickey Dr Steve Burnell

Also Brandon Capital portfolio·Startup Daily·Startup News (WA)·Techboard·Startup Daily

Roche Group

Funding history

Investors

What Roche Group bought

People

Coverage

Billionaires Andrew and Nicola Forrest take aim at peanut allergy